| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperaldosteronism | 41 | 2025 | 252 | 16.720 |
Why?
|
| Aldosterone | 42 | 2024 | 881 | 9.210 |
Why?
|
| Renin | 25 | 2024 | 647 | 5.120 |
Why?
|
| Hypertension | 48 | 2024 | 8626 | 4.340 |
Why?
|
| Adrenal Gland Neoplasms | 13 | 2024 | 730 | 3.360 |
Why?
|
| Renin-Angiotensin System | 14 | 2020 | 737 | 3.360 |
Why?
|
| Adrenalectomy | 9 | 2024 | 344 | 3.340 |
Why?
|
| Adrenal Glands | 13 | 2024 | 558 | 2.840 |
Why?
|
| Adrenal Cortex Neoplasms | 10 | 2024 | 161 | 2.670 |
Why?
|
| Adrenocortical Carcinoma | 7 | 2024 | 87 | 2.020 |
Why?
|
| Adrenocorticotropic Hormone | 6 | 2024 | 616 | 1.990 |
Why?
|
| Parathyroid Hormone | 7 | 2024 | 1789 | 1.960 |
Why?
|
| Hyperparathyroidism, Primary | 4 | 2022 | 163 | 1.910 |
Why?
|
| Sodium, Dietary | 9 | 2020 | 426 | 1.780 |
Why?
|
| Vitamin D | 14 | 2018 | 3272 | 1.740 |
Why?
|
| Paraganglioma | 5 | 2022 | 143 | 1.640 |
Why?
|
| Calcium | 8 | 2024 | 5767 | 1.510 |
Why?
|
| Pheochromocytoma | 6 | 2024 | 323 | 1.470 |
Why?
|
| Receptors, Mineralocorticoid | 6 | 2023 | 167 | 1.450 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 2024 | 77 | 1.380 |
Why?
|
| Angiotensin II | 8 | 2018 | 844 | 1.380 |
Why?
|
| Cushing Syndrome | 2 | 2021 | 241 | 1.260 |
Why?
|
| Adrenal Insufficiency | 7 | 2024 | 194 | 1.250 |
Why?
|
| Hydrocortisone | 10 | 2022 | 1827 | 1.130 |
Why?
|
| Blood Pressure | 17 | 2024 | 8532 | 1.030 |
Why?
|
| Metabolic Diseases | 3 | 2017 | 687 | 0.940 |
Why?
|
| Adenoma | 5 | 2024 | 2152 | 0.930 |
Why?
|
| Adrenocortical Adenoma | 3 | 2022 | 46 | 0.890 |
Why?
|
| Hypocalcemia | 3 | 2024 | 205 | 0.880 |
Why?
|
| Fibroblast Growth Factors | 3 | 2019 | 871 | 0.850 |
Why?
|
| Coordination Complexes | 1 | 2024 | 73 | 0.850 |
Why?
|
| Diet, Sodium-Restricted | 6 | 2020 | 291 | 0.820 |
Why?
|
| Diagnosis, Differential | 42 | 2024 | 12976 | 0.820 |
Why?
|
| Amiloride | 1 | 2022 | 115 | 0.820 |
Why?
|
| Receptors, Calcitriol | 4 | 2013 | 361 | 0.800 |
Why?
|
| Peptides, Cyclic | 1 | 2024 | 390 | 0.760 |
Why?
|
| Glucocorticoids | 15 | 2024 | 2132 | 0.750 |
Why?
|
| Minerals | 3 | 2018 | 278 | 0.750 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2021 | 12 | 0.740 |
Why?
|
| Humans | 199 | 2025 | 765968 | 0.730 |
Why?
|
| Middle Aged | 96 | 2025 | 223009 | 0.710 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2020 | 43 | 0.710 |
Why?
|
| Renal Plasma Flow | 3 | 2017 | 28 | 0.690 |
Why?
|
| Veins | 2 | 2021 | 764 | 0.680 |
Why?
|
| Antihypertensive Agents | 10 | 2024 | 2033 | 0.670 |
Why?
|
| Chest Pain | 6 | 2024 | 1100 | 0.650 |
Why?
|
| Succinate Dehydrogenase | 2 | 2017 | 147 | 0.650 |
Why?
|
| Cardiovascular Diseases | 11 | 2023 | 15652 | 0.640 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2019 | 1514 | 0.630 |
Why?
|
| Renal Insufficiency, Chronic | 5 | 2023 | 2310 | 0.620 |
Why?
|
| West Nile Fever | 1 | 2019 | 77 | 0.620 |
Why?
|
| Cyanosis | 2 | 2018 | 82 | 0.610 |
Why?
|
| Kidney Calculi | 2 | 2020 | 457 | 0.610 |
Why?
|
| Female | 112 | 2025 | 396112 | 0.600 |
Why?
|
| Central Nervous System Cysts | 1 | 2018 | 56 | 0.600 |
Why?
|
| Spironolactone | 4 | 2025 | 415 | 0.580 |
Why?
|
| Male | 109 | 2025 | 363698 | 0.580 |
Why?
|
| Adiposity | 3 | 2018 | 1890 | 0.580 |
Why?
|
| Adult | 83 | 2025 | 223044 | 0.570 |
Why?
|
| Calcitriol | 2 | 2020 | 299 | 0.560 |
Why?
|
| Kidney | 8 | 2023 | 7066 | 0.550 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 341 | 0.550 |
Why?
|
| Obesity | 11 | 2021 | 13076 | 0.550 |
Why?
|
| Hypokalemia | 5 | 2023 | 154 | 0.540 |
Why?
|
| Dyspnea | 13 | 2020 | 1352 | 0.520 |
Why?
|
| Hypoventilation | 1 | 2016 | 43 | 0.520 |
Why?
|
| Hyponatremia | 1 | 2018 | 276 | 0.510 |
Why?
|
| Captopril | 2 | 2013 | 261 | 0.510 |
Why?
|
| Cross-Sectional Studies | 21 | 2022 | 26318 | 0.500 |
Why?
|
| Hyperparathyroidism | 1 | 2017 | 337 | 0.500 |
Why?
|
| Vitamin D Deficiency | 5 | 2018 | 1348 | 0.500 |
Why?
|
| Sleep Apnea, Central | 1 | 2016 | 88 | 0.490 |
Why?
|
| Diabetes Mellitus | 9 | 2022 | 5891 | 0.490 |
Why?
|
| Adiponectin | 2 | 2011 | 1119 | 0.490 |
Why?
|
| Resistin | 3 | 2016 | 174 | 0.470 |
Why?
|
| Body Size | 1 | 2017 | 459 | 0.460 |
Why?
|
| Abdominal Pain | 7 | 2021 | 1069 | 0.460 |
Why?
|
| Kidney Diseases | 3 | 2020 | 2098 | 0.440 |
Why?
|
| Diarrhea | 3 | 2019 | 1316 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 10 | 2024 | 12240 | 0.430 |
Why?
|
| Insulinoma | 2 | 2011 | 121 | 0.430 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2017 | 587 | 0.420 |
Why?
|
| Incidence | 19 | 2021 | 21480 | 0.420 |
Why?
|
| Electrocardiography | 15 | 2024 | 6404 | 0.420 |
Why?
|
| Headache | 2 | 2018 | 1259 | 0.410 |
Why?
|
| Calcium Channel Blockers | 1 | 2016 | 686 | 0.400 |
Why?
|
| Sodium | 2 | 2020 | 1591 | 0.400 |
Why?
|
| Ebolavirus | 1 | 2015 | 250 | 0.390 |
Why?
|
| Wernicke Encephalopathy | 1 | 2012 | 29 | 0.390 |
Why?
|
| Ultraviolet Rays | 1 | 2017 | 1102 | 0.390 |
Why?
|
| Fever | 7 | 2020 | 1603 | 0.390 |
Why?
|
| Atherosclerosis | 3 | 2022 | 3424 | 0.390 |
Why?
|
| Atrial Fibrillation | 4 | 2024 | 5189 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1140 | 0.380 |
Why?
|
| Thiamine Deficiency | 1 | 2012 | 48 | 0.380 |
Why?
|
| Risk Factors | 32 | 2024 | 74840 | 0.380 |
Why?
|
| Blood Glucose | 8 | 2017 | 6424 | 0.380 |
Why?
|
| Tracheomalacia | 1 | 2012 | 63 | 0.380 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2012 | 84 | 0.380 |
Why?
|
| Prediabetic State | 2 | 2016 | 548 | 0.370 |
Why?
|
| Hydroxycholecalciferols | 1 | 2011 | 44 | 0.370 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2012 | 92 | 0.370 |
Why?
|
| Thiamine | 1 | 2012 | 160 | 0.360 |
Why?
|
| Fluid Therapy | 1 | 2015 | 584 | 0.360 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2012 | 177 | 0.350 |
Why?
|
| Adipokines | 1 | 2012 | 308 | 0.350 |
Why?
|
| Cholecalciferol | 2 | 2012 | 550 | 0.350 |
Why?
|
| Pericardial Effusion | 1 | 2012 | 246 | 0.340 |
Why?
|
| Calcifediol | 1 | 2011 | 156 | 0.340 |
Why?
|
| Prions | 1 | 2012 | 182 | 0.340 |
Why?
|
| Kidney Glomerulus | 1 | 2012 | 568 | 0.340 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1321 | 0.340 |
Why?
|
| Diagnostic Errors | 2 | 2019 | 1275 | 0.340 |
Why?
|
| Heart Defects, Congenital | 2 | 2018 | 4697 | 0.330 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 424 | 0.330 |
Why?
|
| Confusion | 2 | 2011 | 277 | 0.330 |
Why?
|
| Diabetes Insipidus | 1 | 2010 | 143 | 0.320 |
Why?
|
| Connective Tissue Diseases | 1 | 2012 | 284 | 0.320 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2023 | 855 | 0.320 |
Why?
|
| Bone Density Conservation Agents | 2 | 2017 | 791 | 0.320 |
Why?
|
| Down-Regulation | 1 | 2016 | 2927 | 0.310 |
Why?
|
| Exanthema | 5 | 2020 | 502 | 0.310 |
Why?
|
| Computer-Assisted Instruction | 1 | 2012 | 368 | 0.310 |
Why?
|
| Hormones | 1 | 2012 | 863 | 0.310 |
Why?
|
| Fatal Outcome | 9 | 2021 | 1831 | 0.300 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2020 | 258 | 0.300 |
Why?
|
| Dietary Supplements | 2 | 2012 | 3425 | 0.300 |
Why?
|
| Aged | 39 | 2024 | 171117 | 0.300 |
Why?
|
| Liver | 3 | 2021 | 7562 | 0.300 |
Why?
|
| Retrospective Studies | 22 | 2024 | 81514 | 0.290 |
Why?
|
| Linear Models | 7 | 2017 | 5876 | 0.290 |
Why?
|
| Medical Staff, Hospital | 1 | 2012 | 601 | 0.290 |
Why?
|
| Lung | 13 | 2021 | 10033 | 0.290 |
Why?
|
| Fasting | 4 | 2017 | 1606 | 0.290 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2020 | 1808 | 0.290 |
Why?
|
| Prevalence | 8 | 2021 | 15842 | 0.290 |
Why?
|
| Diabetic Angiopathies | 4 | 2017 | 805 | 0.280 |
Why?
|
| Mitotane | 2 | 2024 | 20 | 0.280 |
Why?
|
| Pancreas | 2 | 2011 | 1700 | 0.280 |
Why?
|
| Bone Density | 3 | 2017 | 3491 | 0.270 |
Why?
|
| Graves Disease | 2 | 2021 | 241 | 0.270 |
Why?
|
| Hypoglycemia | 2 | 2011 | 896 | 0.270 |
Why?
|
| Potassium | 3 | 2022 | 1311 | 0.270 |
Why?
|
| Cough | 8 | 2020 | 597 | 0.270 |
Why?
|
| Insulin Resistance | 4 | 2016 | 3985 | 0.270 |
Why?
|
| Diuretics | 2 | 2024 | 613 | 0.270 |
Why?
|
| Drug Resistance | 1 | 2012 | 1591 | 0.260 |
Why?
|
| Body Mass Index | 4 | 2017 | 13039 | 0.250 |
Why?
|
| Muscle Weakness | 3 | 2021 | 413 | 0.240 |
Why?
|
| Glomerular Filtration Rate | 4 | 2022 | 2233 | 0.240 |
Why?
|
| Multivariate Analysis | 8 | 2017 | 12056 | 0.240 |
Why?
|
| Syndrome | 2 | 2022 | 3271 | 0.240 |
Why?
|
| Fanconi Syndrome | 2 | 2016 | 35 | 0.240 |
Why?
|
| Histoplasma | 2 | 2017 | 40 | 0.240 |
Why?
|
| Prospective Studies | 15 | 2024 | 54802 | 0.240 |
Why?
|
| Prognosis | 10 | 2022 | 29922 | 0.240 |
Why?
|
| Dermatomyositis | 2 | 2019 | 261 | 0.230 |
Why?
|
| Histoplasmosis | 2 | 2017 | 63 | 0.230 |
Why?
|
| Osteoporosis | 1 | 2014 | 1582 | 0.230 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2024 | 705 | 0.230 |
Why?
|
| Fatigue | 7 | 2021 | 1549 | 0.230 |
Why?
|
| RNA, Catalytic | 2 | 2001 | 52 | 0.230 |
Why?
|
| Caveolin 1 | 2 | 2016 | 255 | 0.230 |
Why?
|
| Genetic Testing | 2 | 2015 | 3595 | 0.230 |
Why?
|
| Colitis, Ulcerative | 2 | 2015 | 1915 | 0.230 |
Why?
|
| China | 7 | 2018 | 2385 | 0.220 |
Why?
|
| Glucose Intolerance | 3 | 2017 | 580 | 0.220 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2011 | 1083 | 0.220 |
Why?
|
| Vitamins | 1 | 2012 | 1630 | 0.210 |
Why?
|
| Hypothyroidism | 3 | 2019 | 667 | 0.210 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 254 | 0.210 |
Why?
|
| Pericarditis | 1 | 2024 | 137 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2021 | 11868 | 0.200 |
Why?
|
| Hypotension | 4 | 2023 | 885 | 0.200 |
Why?
|
| Longitudinal Studies | 8 | 2021 | 14751 | 0.200 |
Why?
|
| Osteomalacia | 2 | 2020 | 60 | 0.200 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 4247 | 0.200 |
Why?
|
| Staphylococcal Infections | 2 | 2024 | 1393 | 0.200 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2019 | 451 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2020 | 2159 | 0.190 |
Why?
|
| Dementia | 2 | 2018 | 2744 | 0.190 |
Why?
|
| Propionibacteriaceae | 1 | 2021 | 10 | 0.190 |
Why?
|
| Pericardiocentesis | 2 | 2024 | 78 | 0.190 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2024 | 1534 | 0.190 |
Why?
|
| Sweating | 2 | 2020 | 155 | 0.190 |
Why?
|
| Lemierre Syndrome | 1 | 2021 | 14 | 0.190 |
Why?
|
| Young Adult | 18 | 2021 | 59889 | 0.190 |
Why?
|
| Metanephrine | 1 | 2021 | 25 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 13 | 2022 | 20659 | 0.190 |
Why?
|
| Acanthosis Nigricans | 1 | 2021 | 49 | 0.190 |
Why?
|
| Antithyroid Agents | 1 | 2021 | 72 | 0.190 |
Why?
|
| Endocrinology | 2 | 2024 | 444 | 0.180 |
Why?
|
| Pulmonary Embolism | 3 | 2019 | 2598 | 0.180 |
Why?
|
| Aerospace Medicine | 1 | 2022 | 95 | 0.180 |
Why?
|
| Patient Satisfaction | 2 | 2019 | 3475 | 0.180 |
Why?
|
| Autonomic Pathways | 1 | 2021 | 31 | 0.180 |
Why?
|
| Hyperbilirubinemia | 1 | 2021 | 74 | 0.180 |
Why?
|
| Mass Screening | 3 | 2024 | 5446 | 0.180 |
Why?
|
| Conservation of Natural Resources | 1 | 2023 | 209 | 0.180 |
Why?
|
| Leptospirosis | 1 | 2021 | 45 | 0.170 |
Why?
|
| Inpatients | 1 | 2012 | 2564 | 0.170 |
Why?
|
| Thorax | 1 | 2023 | 554 | 0.170 |
Why?
|
| Mesenchymoma | 1 | 2020 | 50 | 0.170 |
Why?
|
| Heart | 2 | 2023 | 4414 | 0.170 |
Why?
|
| Aged, 80 and over | 11 | 2019 | 59489 | 0.170 |
Why?
|
| Cohort Studies | 12 | 2025 | 41649 | 0.170 |
Why?
|
| Metals | 2 | 2001 | 710 | 0.170 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2966 | 0.170 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2020 | 50 | 0.160 |
Why?
|
| Mutation | 5 | 2019 | 30198 | 0.160 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2024 | 531 | 0.160 |
Why?
|
| Irritable Mood | 1 | 2021 | 196 | 0.160 |
Why?
|
| Copper | 2 | 2019 | 367 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 7 | 2024 | 7478 | 0.160 |
Why?
|
| Anemia, Macrocytic | 1 | 2019 | 54 | 0.160 |
Why?
|
| Hypophosphatemia | 1 | 2020 | 92 | 0.160 |
Why?
|
| Addison Disease | 1 | 2019 | 48 | 0.160 |
Why?
|
| Mineralocorticoid Excess Syndrome, Apparent | 1 | 2019 | 1 | 0.160 |
Why?
|
| Hypercalcemia | 2 | 2019 | 426 | 0.160 |
Why?
|
| Acyltransferases | 1 | 2001 | 305 | 0.160 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2012 | 303 | 0.160 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2019 | 18 | 0.160 |
Why?
|
| Dexamethasone | 2 | 2024 | 1963 | 0.160 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2021 | 127 | 0.160 |
Why?
|
| Clavicle | 1 | 2021 | 224 | 0.160 |
Why?
|
| Adolescent | 15 | 2022 | 88835 | 0.160 |
Why?
|
| Receptors, CXCR4 | 1 | 2024 | 728 | 0.160 |
Why?
|
| Ethylene Glycol | 1 | 2019 | 31 | 0.160 |
Why?
|
| Exercise | 1 | 2016 | 5937 | 0.160 |
Why?
|
| Foot Diseases | 1 | 2020 | 147 | 0.160 |
Why?
|
| Sodium Bicarbonate | 1 | 2019 | 59 | 0.160 |
Why?
|
| Penicillin G Benzathine | 1 | 2018 | 24 | 0.150 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2020 | 156 | 0.150 |
Why?
|
| Arteriosclerosis | 3 | 2016 | 1053 | 0.150 |
Why?
|
| Biopsy | 6 | 2021 | 6763 | 0.150 |
Why?
|
| Endocrine System Diseases | 1 | 2020 | 243 | 0.150 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2019 | 166 | 0.150 |
Why?
|
| Blood | 1 | 2021 | 597 | 0.150 |
Why?
|
| Taste Disorders | 1 | 2018 | 37 | 0.150 |
Why?
|
| Blood Viscosity | 1 | 2018 | 125 | 0.150 |
Why?
|
| Sella Turcica | 1 | 2018 | 117 | 0.150 |
Why?
|
| Taste Perception | 1 | 2018 | 38 | 0.150 |
Why?
|
| Anemia, Pernicious | 1 | 2018 | 16 | 0.150 |
Why?
|
| Italy | 1 | 2020 | 854 | 0.150 |
Why?
|
| Drug Therapy, Combination | 3 | 2024 | 6309 | 0.150 |
Why?
|
| Combined Modality Therapy | 4 | 2020 | 8529 | 0.150 |
Why?
|
| Prednisone | 4 | 2017 | 1565 | 0.150 |
Why?
|
| Olfactory Perception | 1 | 2018 | 64 | 0.150 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15880 | 0.140 |
Why?
|
| Superior Vena Cava Syndrome | 1 | 2018 | 57 | 0.140 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 122 | 0.140 |
Why?
|
| Zona Fasciculata | 1 | 2017 | 7 | 0.140 |
Why?
|
| Radiography, Abdominal | 1 | 2021 | 544 | 0.140 |
Why?
|
| Zona Reticularis | 1 | 2017 | 8 | 0.140 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2022 | 340 | 0.140 |
Why?
|
| Thoracostomy | 1 | 2018 | 78 | 0.140 |
Why?
|
| Amenorrhea | 1 | 2021 | 470 | 0.140 |
Why?
|
| Meningitis | 1 | 2019 | 216 | 0.140 |
Why?
|
| Eosinophilic Granuloma | 1 | 2017 | 27 | 0.140 |
Why?
|
| Nasopharynx | 1 | 2020 | 419 | 0.140 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2017 | 62 | 0.140 |
Why?
|
| Calcium, Dietary | 1 | 2020 | 526 | 0.140 |
Why?
|
| Adrenal Cortex | 1 | 2017 | 134 | 0.140 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2017 | 99 | 0.140 |
Why?
|
| Splenic Infarction | 1 | 2016 | 12 | 0.140 |
Why?
|
| Quality of Health Care | 1 | 2012 | 4300 | 0.140 |
Why?
|
| Brugada Syndrome | 1 | 2018 | 97 | 0.140 |
Why?
|
| Echocardiography | 9 | 2024 | 5045 | 0.140 |
Why?
|
| Taste | 1 | 2018 | 190 | 0.140 |
Why?
|
| Zona Glomerulosa | 1 | 2017 | 87 | 0.140 |
Why?
|
| Prehypertension | 1 | 2017 | 63 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 990 | 0.140 |
Why?
|
| Adrenocortical Hyperfunction | 1 | 2016 | 13 | 0.140 |
Why?
|
| Endothelium, Vascular | 3 | 2022 | 4427 | 0.140 |
Why?
|
| Nausea | 3 | 2019 | 680 | 0.130 |
Why?
|
| Encephalitis, Varicella Zoster | 1 | 2016 | 7 | 0.130 |
Why?
|
| Celiac Artery | 1 | 2016 | 65 | 0.130 |
Why?
|
| Sulfotransferases | 1 | 2017 | 151 | 0.130 |
Why?
|
| Phenotype | 4 | 2019 | 16721 | 0.130 |
Why?
|
| Hypopituitarism | 1 | 2018 | 254 | 0.130 |
Why?
|
| Blood Pressure Determination | 2 | 2017 | 647 | 0.130 |
Why?
|
| Foramen Ovale, Patent | 1 | 2019 | 211 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5444 | 0.130 |
Why?
|
| Temporal Arteries | 1 | 2017 | 154 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2012 | 4863 | 0.130 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2016 | 73 | 0.130 |
Why?
|
| Gastric Bypass | 2 | 2017 | 820 | 0.130 |
Why?
|
| Radiography, Thoracic | 5 | 2021 | 1315 | 0.130 |
Why?
|
| Gastric Fistula | 1 | 2017 | 73 | 0.130 |
Why?
|
| Foot | 1 | 2020 | 573 | 0.130 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2017 | 282 | 0.130 |
Why?
|
| Cerebral Hemorrhage | 2 | 2017 | 2648 | 0.130 |
Why?
|
| Smell | 1 | 2018 | 259 | 0.130 |
Why?
|
| Intestinal Fistula | 1 | 2017 | 146 | 0.130 |
Why?
|
| Dyslipidemias | 2 | 2021 | 869 | 0.130 |
Why?
|
| Incidental Findings | 1 | 2021 | 697 | 0.130 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 207 | 0.130 |
Why?
|
| Maine | 1 | 2016 | 146 | 0.130 |
Why?
|
| Tricuspid Valve | 1 | 2019 | 422 | 0.130 |
Why?
|
| Colon | 2 | 2015 | 1795 | 0.130 |
Why?
|
| Cardiac Tamponade | 1 | 2017 | 176 | 0.130 |
Why?
|
| Olfaction Disorders | 1 | 2018 | 223 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2017 | 242 | 0.120 |
Why?
|
| Wasps | 1 | 2015 | 15 | 0.120 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 1067 | 0.120 |
Why?
|
| Wasp Venoms | 1 | 2015 | 20 | 0.120 |
Why?
|
| Syphilis | 1 | 2018 | 243 | 0.120 |
Why?
|
| Lupus Nephritis | 1 | 2019 | 320 | 0.120 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2016 | 94 | 0.120 |
Why?
|
| Hepatitis B, Chronic | 2 | 2024 | 412 | 0.120 |
Why?
|
| Hemodynamics | 2 | 2018 | 4184 | 0.120 |
Why?
|
| Acyclovir | 1 | 2016 | 267 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 1604 | 0.120 |
Why?
|
| Follow-Up Studies | 6 | 2020 | 39193 | 0.120 |
Why?
|
| False Negative Reactions | 1 | 2016 | 573 | 0.120 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2015 | 102 | 0.120 |
Why?
|
| Lung Neoplasms | 5 | 2019 | 13451 | 0.120 |
Why?
|
| Primaquine | 1 | 2014 | 28 | 0.120 |
Why?
|
| Insect Bites and Stings | 1 | 2015 | 71 | 0.120 |
Why?
|
| Consensus | 1 | 2025 | 3202 | 0.120 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2019 | 363 | 0.120 |
Why?
|
| Observer Variation | 1 | 2021 | 2615 | 0.120 |
Why?
|
| United States | 12 | 2022 | 72903 | 0.120 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2019 | 669 | 0.120 |
Why?
|
| Protective Clothing | 1 | 2015 | 103 | 0.120 |
Why?
|
| p-Aminohippuric Acid | 1 | 2014 | 36 | 0.120 |
Why?
|
| Liberia | 1 | 2015 | 176 | 0.120 |
Why?
|
| Albuminuria | 1 | 2018 | 660 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2018 | 392 | 0.110 |
Why?
|
| Adipose Tissue | 3 | 2017 | 3312 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2020 | 1192 | 0.110 |
Why?
|
| Heart Rate | 2 | 2016 | 4204 | 0.110 |
Why?
|
| Asthma | 2 | 2017 | 6270 | 0.110 |
Why?
|
| Leukemia, Hairy Cell | 1 | 2014 | 82 | 0.110 |
Why?
|
| Furosemide | 1 | 2015 | 175 | 0.110 |
Why?
|
| Tryptases | 1 | 2015 | 177 | 0.110 |
Why?
|
| Fever of Unknown Origin | 1 | 2014 | 94 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2020 | 645 | 0.110 |
Why?
|
| Vancomycin | 1 | 2017 | 504 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 836 | 0.110 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2014 | 100 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2019 | 1441 | 0.110 |
Why?
|
| Water-Electrolyte Balance | 1 | 2015 | 325 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 16047 | 0.110 |
Why?
|
| Pneumocystis carinii | 1 | 2014 | 70 | 0.110 |
Why?
|
| Arthralgia | 2 | 2020 | 459 | 0.110 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2015 | 157 | 0.110 |
Why?
|
| Gait Disorders, Neurologic | 2 | 2014 | 246 | 0.110 |
Why?
|
| Regional Blood Flow | 1 | 2017 | 1478 | 0.110 |
Why?
|
| Giant Cell Arteritis | 1 | 2017 | 302 | 0.110 |
Why?
|
| Polyarteritis Nodosa | 1 | 2013 | 68 | 0.110 |
Why?
|
| Tachycardia | 3 | 2021 | 594 | 0.110 |
Why?
|
| Heart Failure | 3 | 2024 | 11840 | 0.110 |
Why?
|
| Rheumatic Fever | 1 | 2013 | 73 | 0.100 |
Why?
|
| Ultrasonography | 4 | 2016 | 5993 | 0.100 |
Why?
|
| Endocarditis, Bacterial | 1 | 2017 | 434 | 0.100 |
Why?
|
| Respiratory Sounds | 1 | 2017 | 705 | 0.100 |
Why?
|
| Mastocytosis | 1 | 2015 | 151 | 0.100 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2013 | 72 | 0.100 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 314 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2020 | 22223 | 0.100 |
Why?
|
| Immunosuppressive Agents | 4 | 2019 | 4209 | 0.100 |
Why?
|
| Lymph Nodes | 3 | 2019 | 3454 | 0.100 |
Why?
|
| Pericardium | 1 | 2017 | 679 | 0.100 |
Why?
|
| Plasmodium vivax | 1 | 2014 | 202 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2020 | 2599 | 0.100 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2014 | 239 | 0.100 |
Why?
|
| Edema | 2 | 2016 | 760 | 0.100 |
Why?
|
| Malaria, Vivax | 1 | 2014 | 168 | 0.100 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 970 | 0.100 |
Why?
|
| Lymphatic Diseases | 2 | 2014 | 317 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2017 | 625 | 0.100 |
Why?
|
| Infarction | 1 | 2013 | 246 | 0.100 |
Why?
|
| Hypertension, Renal | 1 | 2012 | 131 | 0.100 |
Why?
|
| Blood Vessels | 1 | 2018 | 1113 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2015 | 715 | 0.100 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2019 | 1061 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 109 | 0.100 |
Why?
|
| Leg | 2 | 2017 | 1080 | 0.100 |
Why?
|
| Pain | 4 | 2024 | 5077 | 0.100 |
Why?
|
| Babesiosis | 1 | 2013 | 92 | 0.100 |
Why?
|
| Infusions, Intravenous | 2 | 2016 | 2229 | 0.100 |
Why?
|
| Shock, Cardiogenic | 2 | 2017 | 704 | 0.100 |
Why?
|
| Epinephrine | 1 | 2015 | 783 | 0.100 |
Why?
|
| Nutritional Status | 1 | 2020 | 1620 | 0.100 |
Why?
|
| Brain | 4 | 2020 | 27171 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2012 | 5946 | 0.100 |
Why?
|
| Plasmodium | 1 | 2014 | 248 | 0.090 |
Why?
|
| Papilledema | 1 | 2013 | 130 | 0.090 |
Why?
|
| Coronary Stenosis | 1 | 2017 | 800 | 0.090 |
Why?
|
| Immunocompromised Host | 2 | 2014 | 866 | 0.090 |
Why?
|
| Rest | 1 | 2016 | 942 | 0.090 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2015 | 333 | 0.090 |
Why?
|
| Parathyroid Glands | 1 | 2013 | 521 | 0.090 |
Why?
|
| Celiac Disease | 1 | 2019 | 820 | 0.090 |
Why?
|
| Trypanosoma cruzi | 1 | 2013 | 200 | 0.090 |
Why?
|
| Bundle-Branch Block | 1 | 2013 | 280 | 0.090 |
Why?
|
| Heart Neoplasms | 1 | 2015 | 375 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7425 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4562 | 0.090 |
Why?
|
| Heart Arrest | 1 | 2021 | 1516 | 0.090 |
Why?
|
| Pleura | 1 | 2012 | 240 | 0.090 |
Why?
|
| Colchicine | 1 | 2012 | 256 | 0.090 |
Why?
|
| Nephrotic Syndrome | 1 | 2015 | 380 | 0.090 |
Why?
|
| Defibrillators, Implantable | 2 | 2018 | 1490 | 0.090 |
Why?
|
| Antibodies, Antinuclear | 1 | 2012 | 340 | 0.090 |
Why?
|
| Sirolimus | 1 | 2018 | 1545 | 0.090 |
Why?
|
| Pulmonary Atelectasis | 1 | 2012 | 161 | 0.090 |
Why?
|
| Radiography | 4 | 2019 | 6919 | 0.090 |
Why?
|
| Narcotic Antagonists | 1 | 2015 | 590 | 0.090 |
Why?
|
| Weight Gain | 1 | 2021 | 2355 | 0.090 |
Why?
|
| Metabolome | 1 | 2018 | 1005 | 0.090 |
Why?
|
| Infusions, Parenteral | 1 | 2010 | 395 | 0.090 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2021 | 1379 | 0.090 |
Why?
|
| Syncope | 1 | 2013 | 429 | 0.090 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2014 | 664 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2012 | 8730 | 0.090 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2012 | 428 | 0.090 |
Why?
|
| Antidiuretic Agents | 1 | 2010 | 21 | 0.090 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2011 | 125 | 0.090 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 2010 | 101 | 0.090 |
Why?
|
| Dizziness | 2 | 2011 | 269 | 0.090 |
Why?
|
| Genetic Counseling | 1 | 2014 | 634 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 2176 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 1896 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 655 | 0.080 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2010 | 87 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1560 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 14652 | 0.080 |
Why?
|
| Pedigree | 1 | 2017 | 4526 | 0.080 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2012 | 520 | 0.080 |
Why?
|
| France | 1 | 2010 | 495 | 0.080 |
Why?
|
| Hypernatremia | 1 | 2010 | 78 | 0.080 |
Why?
|
| Glucose | 2 | 2022 | 4335 | 0.080 |
Why?
|
| Nurses | 2 | 2017 | 2505 | 0.080 |
Why?
|
| Gene Frequency | 2 | 2016 | 3624 | 0.080 |
Why?
|
| Aging | 2 | 2017 | 8731 | 0.080 |
Why?
|
| Graves Ophthalmopathy | 1 | 2010 | 135 | 0.080 |
Why?
|
| Colonoscopy | 2 | 2015 | 1406 | 0.070 |
Why?
|
| Anaphylaxis | 1 | 2015 | 739 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1892 | 0.070 |
Why?
|
| Fractures, Bone | 1 | 2020 | 2041 | 0.070 |
Why?
|
| Drug Synergism | 1 | 2012 | 1749 | 0.070 |
Why?
|
| Lethargy | 2 | 2019 | 43 | 0.070 |
Why?
|
| Animals | 12 | 2018 | 168764 | 0.070 |
Why?
|
| Uveitis | 1 | 2011 | 398 | 0.070 |
Why?
|
| Antimalarials | 1 | 2014 | 913 | 0.070 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2014 | 838 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2020 | 2821 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2020 | 3251 | 0.070 |
Why?
|
| Nucleic Acid Conformation | 2 | 2001 | 901 | 0.070 |
Why?
|
| Age Factors | 4 | 2021 | 18380 | 0.070 |
Why?
|
| Europe | 2 | 2024 | 3423 | 0.070 |
Why?
|
| Diabetes, Gestational | 1 | 2017 | 1263 | 0.070 |
Why?
|
| Homeostasis | 3 | 2016 | 3336 | 0.070 |
Why?
|
| Pulmonary Artery | 2 | 2012 | 1935 | 0.070 |
Why?
|
| Lyme Disease | 1 | 2013 | 631 | 0.070 |
Why?
|
| Stroke | 2 | 2020 | 9747 | 0.070 |
Why?
|
| Heart Atria | 2 | 2023 | 1363 | 0.070 |
Why?
|
| Vomiting | 2 | 2021 | 647 | 0.070 |
Why?
|
| Leukocyte Count | 2 | 2020 | 1602 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2015 | 2864 | 0.070 |
Why?
|
| Disease Progression | 3 | 2022 | 13632 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 1997 | 0.060 |
Why?
|
| Anxiety | 1 | 2021 | 4671 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 1292 | 0.060 |
Why?
|
| Myocarditis | 1 | 2013 | 802 | 0.060 |
Why?
|
| Endoscopy, Digestive System | 2 | 2019 | 358 | 0.060 |
Why?
|
| Cause of Death | 1 | 2016 | 3708 | 0.060 |
Why?
|
| Environment | 1 | 2011 | 1114 | 0.060 |
Why?
|
| Life Cycle Stages | 2 | 2017 | 161 | 0.060 |
Why?
|
| Pleural Effusion | 2 | 2020 | 346 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 2247 | 0.060 |
Why?
|
| Fetal Diseases | 1 | 2020 | 914 | 0.060 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 587 | 0.060 |
Why?
|
| Models, Animal | 1 | 2011 | 2120 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4353 | 0.060 |
Why?
|
| Malaria | 1 | 2015 | 1246 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2012 | 1194 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 18071 | 0.060 |
Why?
|
| Terbium | 2 | 2001 | 8 | 0.060 |
Why?
|
| Myelolipoma | 1 | 2024 | 14 | 0.060 |
Why?
|
| Suppuration | 1 | 2024 | 61 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 11206 | 0.060 |
Why?
|
| Tachycardia, Ventricular | 1 | 2013 | 1310 | 0.060 |
Why?
|
| Pericarditis, Constrictive | 1 | 2024 | 46 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3432 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 2012 | 9249 | 0.060 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 9071 | 0.060 |
Why?
|
| Cosyntropin | 1 | 2024 | 34 | 0.060 |
Why?
|
| Acute Disease | 3 | 2024 | 7232 | 0.060 |
Why?
|
| Suicide, Attempted | 1 | 2012 | 1409 | 0.050 |
Why?
|
| Anorexia Nervosa | 1 | 2012 | 1328 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 11022 | 0.050 |
Why?
|
| Quality of Life | 2 | 2022 | 13462 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2012 | 2499 | 0.050 |
Why?
|
| Mineralocorticoids | 1 | 2023 | 37 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2011 | 21056 | 0.050 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2014 | 1917 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2015 | 3211 | 0.050 |
Why?
|
| Boston | 2 | 2016 | 9338 | 0.050 |
Why?
|
| Family | 1 | 2014 | 3209 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4772 | 0.050 |
Why?
|
| Deglutition Disorders | 2 | 2021 | 639 | 0.050 |
Why?
|
| Adenocarcinoma | 2 | 2018 | 6364 | 0.050 |
Why?
|
| Thyroidectomy | 2 | 2021 | 916 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2019 | 24282 | 0.050 |
Why?
|
| Melanoma | 2 | 2012 | 5719 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6203 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20124 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2016 | 2788 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2017 | 1180 | 0.050 |
Why?
|
| Ontario | 1 | 2023 | 402 | 0.050 |
Why?
|
| Diet | 1 | 2020 | 8086 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2024 | 3956 | 0.050 |
Why?
|
| Methimazole | 1 | 2021 | 41 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2004 | 429 | 0.050 |
Why?
|
| Thrombocytopenia | 2 | 2021 | 1171 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3222 | 0.050 |
Why?
|
| Catecholamines | 1 | 2022 | 383 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10729 | 0.050 |
Why?
|
| Cations, Divalent | 1 | 2001 | 166 | 0.050 |
Why?
|
| Fibrin | 1 | 2004 | 513 | 0.050 |
Why?
|
| Cobalt | 1 | 2001 | 145 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2020 | 36532 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 4958 | 0.040 |
Why?
|
| Fentanyl | 1 | 2024 | 457 | 0.040 |
Why?
|
| Magnesium | 2 | 2001 | 813 | 0.040 |
Why?
|
| Opioid-Related Disorders | 1 | 2015 | 2178 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 13024 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2025 | 893 | 0.040 |
Why?
|
| Cholesterol | 3 | 2017 | 2898 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2025 | 65188 | 0.040 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 2887 | 0.040 |
Why?
|
| Multiple Myeloma | 1 | 2018 | 5197 | 0.040 |
Why?
|
| Glycosylation | 2 | 2014 | 1100 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2018 | 1426 | 0.040 |
Why?
|
| Spleen | 2 | 2016 | 2296 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 5786 | 0.040 |
Why?
|
| Stroke Volume | 3 | 2021 | 5596 | 0.040 |
Why?
|
| Weight Loss | 3 | 2020 | 2710 | 0.040 |
Why?
|
| Tachycardia, Sinus | 1 | 2020 | 43 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2015 | 3270 | 0.040 |
Why?
|
| Time Factors | 6 | 2019 | 40065 | 0.040 |
Why?
|
| Borrelia | 1 | 2020 | 66 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3807 | 0.040 |
Why?
|
| HTLV-I Antibodies | 1 | 2019 | 35 | 0.040 |
Why?
|
| Propranolol | 1 | 2021 | 492 | 0.040 |
Why?
|
| Cranial Nerves | 1 | 2020 | 95 | 0.040 |
Why?
|
| Reference Values | 2 | 2017 | 4908 | 0.040 |
Why?
|
| Self Report | 2 | 2021 | 3770 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2004 | 1019 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2020 | 239 | 0.040 |
Why?
|
| Triglycerides | 2 | 2017 | 2441 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 2004 | 864 | 0.040 |
Why?
|
| Deficiency Diseases | 1 | 2019 | 75 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2019 | 121 | 0.040 |
Why?
|
| Catheterization | 1 | 2004 | 1425 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 231 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 404 | 0.040 |
Why?
|
| Ceftriaxone | 1 | 2020 | 176 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2020 | 276 | 0.040 |
Why?
|
| Leukocytosis | 1 | 2020 | 248 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3278 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2004 | 920 | 0.040 |
Why?
|
| Brachiocephalic Veins | 1 | 2018 | 21 | 0.040 |
Why?
|
| Taste Buds | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cortisone | 1 | 2019 | 90 | 0.040 |
Why?
|
| Aortic Diseases | 1 | 2004 | 729 | 0.040 |
Why?
|
| Lead | 2 | 2001 | 879 | 0.040 |
Why?
|
| Australia | 1 | 2022 | 1258 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2019 | 180 | 0.040 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 2531 | 0.040 |
Why?
|
| Chile | 1 | 2019 | 258 | 0.040 |
Why?
|
| Calcitonin | 1 | 2019 | 327 | 0.040 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2018 | 37 | 0.040 |
Why?
|
| Introns | 1 | 2000 | 966 | 0.040 |
Why?
|
| Methylmalonic Acid | 1 | 2018 | 50 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1679 | 0.040 |
Why?
|
| Software | 1 | 2012 | 4462 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 612 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2019 | 655 | 0.040 |
Why?
|
| Treponema pallidum | 1 | 2018 | 48 | 0.040 |
Why?
|
| Plasmapheresis | 1 | 2018 | 205 | 0.040 |
Why?
|
| Communication | 1 | 2012 | 3916 | 0.040 |
Why?
|
| Itraconazole | 1 | 2017 | 42 | 0.040 |
Why?
|
| Positron-Emission Tomography | 3 | 2022 | 6547 | 0.040 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2018 | 95 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2022 | 1668 | 0.040 |
Why?
|
| Renal Dialysis | 2 | 2019 | 1799 | 0.040 |
Why?
|
| Poisoning | 1 | 2019 | 254 | 0.040 |
Why?
|
| Thrombosis | 2 | 2018 | 2949 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 1 | 2018 | 123 | 0.040 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2020 | 238 | 0.040 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2017 | 131 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 4058 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 2018 | 198 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 433 | 0.030 |
Why?
|
| Subclavian Artery | 1 | 2017 | 136 | 0.030 |
Why?
|
| Trientine | 1 | 2016 | 12 | 0.030 |
Why?
|
| Sensation Disorders | 1 | 2018 | 160 | 0.030 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 285 | 0.030 |
Why?
|
| Jejunal Diseases | 1 | 2017 | 45 | 0.030 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2017 | 86 | 0.030 |
Why?
|
| Aorta | 1 | 2004 | 2028 | 0.030 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 67 | 0.030 |
Why?
|
| HIV-1 | 1 | 2014 | 6944 | 0.030 |
Why?
|
| Phosphates | 1 | 2020 | 763 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 2477 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 11499 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2019 | 438 | 0.030 |
Why?
|
| Ceruloplasmin | 1 | 2016 | 57 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 552 | 0.030 |
Why?
|
| Disease Management | 2 | 2019 | 2535 | 0.030 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 407 | 0.030 |
Why?
|
| Urinary Bladder | 1 | 2022 | 1154 | 0.030 |
Why?
|
| HIV Infections | 3 | 2024 | 17533 | 0.030 |
Why?
|
| Duodenum | 1 | 2019 | 495 | 0.030 |
Why?
|
| Thyroid Diseases | 1 | 2019 | 388 | 0.030 |
Why?
|
| Doxycycline | 1 | 2018 | 349 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2017 | 386 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2023 | 1272 | 0.030 |
Why?
|
| Oxygen | 2 | 2020 | 4241 | 0.030 |
Why?
|
| Ankle Brachial Index | 1 | 2016 | 166 | 0.030 |
Why?
|
| Contact Tracing | 1 | 2018 | 274 | 0.030 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2019 | 1566 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 14071 | 0.030 |
Why?
|
| Hallucinations | 1 | 2018 | 373 | 0.030 |
Why?
|
| Binding Sites | 2 | 2001 | 6001 | 0.030 |
Why?
|
| Transaminases | 1 | 2016 | 199 | 0.030 |
Why?
|
| Comorbidity | 2 | 2021 | 10563 | 0.030 |
Why?
|
| Shock | 1 | 2018 | 316 | 0.030 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2015 | 139 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 1237 | 0.030 |
Why?
|
| Ulcer | 1 | 2017 | 201 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 607 | 0.030 |
Why?
|
| Insulin | 3 | 2016 | 6599 | 0.030 |
Why?
|
| Intermittent Claudication | 1 | 2017 | 300 | 0.030 |
Why?
|
| Enalapril | 1 | 2017 | 317 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2016 | 23601 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2015 | 155 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2021 | 804 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 2018 | 318 | 0.030 |
Why?
|
| Sex Factors | 2 | 2021 | 10603 | 0.030 |
Why?
|
| Urinalysis | 1 | 2017 | 368 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2012 | 4808 | 0.030 |
Why?
|
| Histamine Antagonists | 1 | 2015 | 93 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1078 | 0.030 |
Why?
|
| Chelating Agents | 1 | 2016 | 380 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 995 | 0.030 |
Why?
|
| Leukotriene Antagonists | 1 | 2015 | 124 | 0.030 |
Why?
|
| Gallbladder | 1 | 2016 | 308 | 0.030 |
Why?
|
| Vitamin B 12 | 1 | 2018 | 532 | 0.030 |
Why?
|
| Simvastatin | 1 | 2017 | 345 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2018 | 912 | 0.030 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 1137 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 856 | 0.030 |
Why?
|
| Mesalamine | 1 | 2015 | 134 | 0.030 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2017 | 477 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 549 | 0.030 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2014 | 61 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 1326 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2020 | 1472 | 0.030 |
Why?
|
| Hypoparathyroidism | 1 | 2015 | 136 | 0.030 |
Why?
|
| Sweet Syndrome | 1 | 2014 | 59 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 2024 | 0.030 |
Why?
|
| Neck | 1 | 2018 | 733 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2019 | 1742 | 0.030 |
Why?
|
| Kinetics | 1 | 2001 | 6274 | 0.030 |
Why?
|
| Hypertriglyceridemia | 1 | 2016 | 290 | 0.030 |
Why?
|
| Trypanocidal Agents | 1 | 2013 | 40 | 0.030 |
Why?
|
| Pregnancy | 2 | 2020 | 30260 | 0.030 |
Why?
|
| Base Sequence | 2 | 2001 | 12403 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2017 | 929 | 0.030 |
Why?
|
| Heart Murmurs | 1 | 2013 | 92 | 0.030 |
Why?
|
| Skin Tests | 1 | 2015 | 630 | 0.030 |
Why?
|
| Logistic Models | 2 | 2019 | 13266 | 0.030 |
Why?
|
| Postural Balance | 1 | 2018 | 637 | 0.030 |
Why?
|
| Chloroquine | 1 | 2014 | 276 | 0.030 |
Why?
|
| Electrolytes | 1 | 2014 | 280 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2013 | 233 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10850 | 0.030 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 5508 | 0.030 |
Why?
|
| Causality | 1 | 2019 | 1248 | 0.030 |
Why?
|
| Diplopia | 1 | 2014 | 217 | 0.030 |
Why?
|
| Hemianopsia | 1 | 2014 | 121 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 2699 | 0.030 |
Why?
|
| Dibenzothiazepines | 1 | 2012 | 101 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2019 | 1003 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2017 | 1693 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2020 | 833 | 0.020 |
Why?
|
| Nitroimidazoles | 1 | 2013 | 117 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2013 | 250 | 0.020 |
Why?
|
| Peptides | 1 | 2004 | 4331 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 12509 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 674 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 644 | 0.020 |
Why?
|
| Proteinuria | 1 | 2015 | 607 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2017 | 770 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2020 | 1784 | 0.020 |
Why?
|
| Scoliosis | 1 | 2019 | 789 | 0.020 |
Why?
|
| Thyroxine | 1 | 2015 | 672 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2001 | 17594 | 0.020 |
Why?
|
| Drug-Eluting Stents | 1 | 2017 | 683 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2015 | 1884 | 0.020 |
Why?
|
| Pruritus | 1 | 2015 | 378 | 0.020 |
Why?
|
| Travel | 1 | 2017 | 806 | 0.020 |
Why?
|
| Diazoxide | 1 | 2011 | 52 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2010 | 5849 | 0.020 |
Why?
|
| Back Pain | 1 | 2015 | 544 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2017 | 1481 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2017 | 2652 | 0.020 |
Why?
|
| Mitral Valve Stenosis | 1 | 2013 | 343 | 0.020 |
Why?
|
| Contrast Media | 1 | 2004 | 5329 | 0.020 |
Why?
|
| Unconsciousness | 1 | 2012 | 250 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2013 | 190 | 0.020 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2014 | 618 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 3715 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 4108 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2016 | 2910 | 0.020 |
Why?
|
| Eye Diseases | 1 | 2016 | 659 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 26346 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 3247 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 691 | 0.020 |
Why?
|
| Anticoagulants | 2 | 2018 | 4862 | 0.020 |
Why?
|
| Penicillins | 1 | 2013 | 404 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2018 | 1568 | 0.020 |
Why?
|
| Desensitization, Immunologic | 1 | 2015 | 544 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1660 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2019 | 4137 | 0.020 |
Why?
|
| Macrophages | 1 | 2004 | 5772 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 1404 | 0.020 |
Why?
|
| Prenatal Care | 1 | 2017 | 1160 | 0.020 |
Why?
|
| Methotrexate | 1 | 2016 | 1722 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1531 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2709 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13648 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1424 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 2056 | 0.020 |
Why?
|
| Endocarditis | 1 | 2013 | 350 | 0.020 |
Why?
|
| Myasthenia Gravis | 1 | 2011 | 214 | 0.020 |
Why?
|
| Aspirin | 1 | 2020 | 3134 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2017 | 2186 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2020 | 2770 | 0.020 |
Why?
|
| Thiophenes | 1 | 2012 | 569 | 0.020 |
Why?
|
| Rats | 2 | 2015 | 23707 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3050 | 0.020 |
Why?
|
| Adenine | 1 | 2014 | 994 | 0.020 |
Why?
|
| Gestational Age | 1 | 2017 | 3609 | 0.020 |
Why?
|
| Rabbits | 2 | 2004 | 4734 | 0.020 |
Why?
|
| Mast Cells | 1 | 2015 | 1412 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2226 | 0.020 |
Why?
|
| Neutrophils | 1 | 2019 | 3776 | 0.020 |
Why?
|
| Delirium | 1 | 2018 | 1707 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2014 | 986 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 988 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2012 | 962 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 2014 | 1384 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2017 | 4493 | 0.020 |
Why?
|
| Life Style | 1 | 2017 | 3926 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 3850 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2015 | 2921 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2334 | 0.010 |
Why?
|
| Infant | 2 | 2017 | 36386 | 0.010 |
Why?
|
| Palliative Care | 1 | 2020 | 3645 | 0.010 |
Why?
|
| Warfarin | 1 | 2013 | 1494 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2016 | 9649 | 0.010 |
Why?
|
| Cholesterol, Dietary | 1 | 2004 | 223 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 2004 | 359 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4348 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15747 | 0.010 |
Why?
|
| Erythrocytes | 1 | 2013 | 2395 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2013 | 1414 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2016 | 10070 | 0.010 |
Why?
|
| Registries | 1 | 2019 | 8297 | 0.010 |
Why?
|
| Mastectomy | 1 | 2011 | 1847 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7838 | 0.010 |
Why?
|
| Heart-Assist Devices | 1 | 2013 | 1296 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2004 | 1140 | 0.010 |
Why?
|
| Length of Stay | 1 | 2016 | 6485 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8501 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10261 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5753 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2016 | 12768 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4528 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8703 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14448 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3529 | 0.010 |
Why?
|
| Lutetium | 1 | 2000 | 38 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2004 | 823 | 0.010 |
Why?
|
| Myocardium | 1 | 2013 | 4760 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 2897 | 0.010 |
Why?
|
| Cations | 1 | 2000 | 240 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2000 | 212 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2011 | 3832 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2004 | 1333 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2012 | 3076 | 0.010 |
Why?
|
| Catalysis | 1 | 2000 | 770 | 0.010 |
Why?
|
| Mice | 2 | 2016 | 81819 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2000 | 1160 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1752 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15398 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 11083 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 2391 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 42500 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 9373 | 0.010 |
Why?
|
| Child | 1 | 2017 | 80564 | 0.000 |
Why?
|